|
Impact of geographic and demographic characteristics on treatment with Lu-PSMA for metastatic castrate-resistant prostate cancer (mCRPC). |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Bluebird Bio (I); Gilead Sciences (I); Johnson & Johnson (I); Merck (I); Novartis (I); Pfizer (I); Portola Pharmaceuticals (I) |
Consulting or Advisory Role - AstraZeneca/Merck; Boehringer Ingelheim (I); Exelixis; Genentech; Health Advances; Novartis (I); Novocure (I) |
Research Funding - AstraZeneca (I); Lilly (I); Pfizer; Trizell (I) |
|
|
|
Consulting or Advisory Role - AstraZeneca; Eisai; Exelixis; Janssen Oncology; Merck; Myovant Sciences; Pfizer/Astellas; Regeneron; Sanofi; Terns Pharmaceuticals; Xencor |
Research Funding - Bristol-Myers Squibb (Inst); Janssen (Inst); Merck (Inst); Pfizer (Inst); Regeneron (Inst); Xencor (Inst) |
Patents, Royalties, Other Intellectual Property - US Patent No. 18/708,529 |
Travel, Accommodations, Expenses - Eisai; Pfizer |
|
|
No Relationships to Disclose |
|
|
Employment - Trevarx Biomedical (I) |
Stock and Other Ownership Interests - ImaginAb; Reflexion Medical; Trevarx Biomedical |
Consulting or Advisory Role - GE Healthcare; Philips Healthcare |
Patents, Royalties, Other Intellectual Property - Trevarx Biomedical (I) |
Other Relationship - ImaginAb; Reflexion Medical; Trevarx Biomedical |
|
|
Honoraria - Telix and Lantheus Pharmaceutical Companies |
Consulting or Advisory Role - Telix and Lantheus Pharmaceutical Companies |
Speakers' Bureau - Telix Pharmaceuticals |
Research Funding - Telix Pharmaceutical - site PI - EAP for Zr-89 Gerintuximab |
Travel, Accommodations, Expenses - Telix and Lantheus Pharmaceutical Companies |
|
|
Stock and Other Ownership Interests - Molecular Targeting Technologies; Trevarx Biomedical |
Consulting or Advisory Role - Curium Pharma; Molecular Targeting Technologies |
Research Funding - Fusion Pharmaceuticals (Inst); Lantheus Medical Imaging (Inst); POINT Biopharma; RayzeBio (Inst) |
Patents, Royalties, Other Intellectual Property - IP that has been licensed to Trevarx (Inst) |
Other Relationship - ITM Oncologics; RadMD |
|
|
No Relationships to Disclose |